Press Releases

Press Releases

All Releases
Jul 29, 2015
NEW YORK --(BUSINESS WIRE)-- Ophthotech Corporation (Nasdaq:OPHT) today announced that it will report its second quarter 2015 financial results on Wednesday, August 5, 2015 . Following the announcement, Ophthotech's management team will host a live conference call and webcast at 8:00 a.m.
Jul 21, 2015
Dr. David T. Shima , a Pioneer, World Leader and Expert in Ocular Angiogenesis and Vascular Cell Biology, Appointed Chief Scientific Officer - Henric Bjarke Joins as Chief Commercial Officer; Brings a Proven Track Record with Major Product Launches and Ophthalmic Domain Expertise - NEW YORK
Jun 03, 2015
- Webcast Available Through Ophthotech Website - NEW YORK --(BUSINESS WIRE)-- Ophthotech Corporation (NASDAQ:OPHT) announced today that David R. Guyer, M.D., Chief Executive Officer and Chairman of the Board, will present an overview of the Company at the Goldman Sachs 36 th Annual Global
May 13, 2015
- Webcast Available Through Ophthotech Website - NEW YORK --(BUSINESS WIRE)-- Ophthotech Corporation (NASDAQ: OPHT) announced today that David R. Guyer, M.D., Chief Executive Officer and Chairman of the Board, will present an overview of the Company at the UBS Global Healthcare Conference in New
May 11, 2015
- Conference Call and Webcast Today, May 11, 2015 , at 5:00 p.m. ET - NEW YORK --(BUSINESS WIRE)-- Ophthotech Corporation (Nasdaq:OPHT) today announced financial results for the first quarter ended March 31, 2015 and provided an update on the Company's business and product development programs.
May 11, 2015
- Conference Call and Webcast Today , May 11, 2015 at 5:00 p.m. ET - NEW YORK --(BUSINESS WIRE)-- Ophthotech Corporation (Nasdaq: OPHT) today announced the completion of patient recruitment of its first Phase 3 trial of Fovista ® in combination with Lucentis ® (ranibizumab).
May 06, 2015
- Webcast Available Through Ophthotech Website - NEW YORK --(BUSINESS WIRE)-- Ophthotech Corporation (NASDAQ:OPHT) announced today that David R. Guyer, M.D., Chief Executive Officer and Chairman of the Board, will present an overview of the Company at the Bank of America Merrill Lynch 2015 Health
May 05, 2015
NEW YORK --(BUSINESS WIRE)-- Ophthotech Corporation (Nasdaq:OPHT) today announced that it will release its first quarter 2015 financial results after close of market on Monday, May 11, 2015 . Following the announcement, Ophthotech's management will host a live conference call and webcast at 5:00
May 04, 2015
- Webcast Available Through Ophthotech Website - NEW YORK --(BUSINESS WIRE)-- Ophthotech Corporation (NASDAQ: OPHT) announced today that David R. Guyer, M.D., Chief Executive Officer and Chairman of the Board, will present an overview of the Company at the Deutsche Bank 40 th Annual Health Care
Mar 10, 2015
- Milestone Triggered by Reaching Second Enrollment Goal in the Fovista ® Phase 3 Program - NEW YORK --(BUSINESS WIRE)-- Ophthotech Corporation (Nasdaq:OPHT) today announced that it has achieved a second $50 million enrollment milestone from Novartis Pharma AG as part of the ex-US licensing
Mar 03, 2015
- Webcast Available Through Ophthotech Website - NEW YORK --(BUSINESS WIRE)-- Ophthotech Corporation (NASDAQ:OPHT) announced today that David R. Guyer, M.D., Chief Executive Officer and Chairman of the Board, will present an overview of the Company at the Barclays Capital Global Healthcare
Feb 23, 2015
- Conference Call and Webcast Today, February 23 , at 5:00 p.m. ET - NEW YORK --(BUSINESS WIRE)-- Ophthotech Corporation (Nasdaq:OPHT) today announced financial results for the fourth quarter and full year ended December 31, 2014 and provided an update on the Company's business and product
Feb 18, 2015
NEW YORK --(BUSINESS WIRE)-- Ophthotech Corporation (Nasdaq:OPHT) today announced that its fourth quarter and year ended December 31, 2014 financial results will be released on Monday, February 23, 2015 . Following the announcement, Ophthotech's management will host a live conference call and
Feb 05, 2015
- Webcast Available Through Ophthotech Website - NEW YORK --(BUSINESS WIRE)-- Ophthotech Corporation (NASDAQ:OPHT) announced today that David R. Guyer, M.D., Chief Executive Officer and Chairman of the Board, will present an overview of the Company at the Leerink Global Healthcare Conference in New
Jan 05, 2015
- Webcast Available Through Ophthotech Website - NEW YORK --(BUSINESS WIRE)-- Ophthotech Corporation (NASDAQ:OPHT) announced today that David R. Guyer, M.D., Chief Executive Officer and Chairman of the Board, will present an overview of the Company at the 33rd Annual J.P.
Dec 15, 2014
NEW YORK --(BUSINESS WIRE)-- Ophthotech Corporation (NASDAQ: OPHT) today announced that it has been selected for addition to the NASDAQ Biotechnology Index (NASDAQ: NBI). The addition to the NASDAQ Biotechnology Index will become effective upon market open on December 22, 2014 .
Dec 02, 2014
- Webcast Available Through Ophthotech Website - NEW YORK --(BUSINESS WIRE)-- Ophthotech Corporation (NASDAQ:OPHT) announced today that David R. Guyer, M.D., Chairman of the Board and Chief Executive Officer, will present an overview of the Company at the Oppenheimer 25 th Annual Healthcare
Nov 13, 2014
- Webcast Available Through Ophthotech Website - NEW YORK --(BUSINESS WIRE)-- Ophthotech Corporation (NASDAQ:OPHT) announced today that David R. Guyer, M.D., Chief Executive Officer and Chairman of the Board, will present an overview of the Company at the Stifel 2014 Healthcare Conference in New
Nov 11, 2014
- Conference Call and Webcast, Today, November 11 , at 8:00 a.m. ET - - Ophthotech Achieves Enrollment Milestone Triggering Third and Final Tranche in Royalty Financing with Novo A/S - - Ophthotech Signs Research and Exclusive Option Agreement to License a VEGF Tyrosine Kinase Inhibitor for the
Nov 04, 2014
- Webcast Available Through Ophthotech Website - NEW YORK --(BUSINESS WIRE)-- Ophthotech Corporation (NASDAQ:OPHT) announced today that David R. Guyer, M.D., Chief Executive Officer and Chairman of the Board, will present an overview of the Company at the 2014 Credit Suisse Annual Healthcare